Last reviewed · How we verify
NCT02429479
Preparing Family Caregivers to Make Medical Decisions for Their Loved Ones
NA trial testing Making Your Wishes Known in Neoplasms in 285 participants. Completed in 30 June 2021.
30 June 2017
Quick facts
| Lead sponsor | Milton S. Hershey Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 285 |
| Start date | 1 June 2013 |
| Primary completion | 30 June 2017 |
| Estimated completion | 30 June 2021 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Making Your Wishes Known
- Standard advance care planning
Conditions studied
- Neoplasms — all drugs for Neoplasms →
- Heart Failure — all drugs for Heart Failure →
- Kidney Diseases — all drugs for Kidney Diseases →
- Lung Diseases — all drugs for Lung Diseases →
Sponsor
Milton S. Hershey Medical Center
Who can join
18 and older, any sex, with Neoplasms or Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overarching goal of the project is to improve the process and experience of surrogate decision-making by family caregivers. Since feeling unprepared to make surrogate decisions is a major contributor to caregiver stress, the primary outcome is caregiver self-efficacy --i.e., caregivers' assessment of how well prepared they feel to serve effectively as a surrogate decision-maker. Through follow-on Renewal funding, we are now also qualitatively examining family caregivers' experience with surrogate decision-making.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
A Randomized Controlled Trial of Strategies to Improve Family Members' Preparedness for Surrogate Decision-Making.
Green MJ, Van Scoy LJ, Foy AJ, Stewart RR, et al · · 2018 · cited 37× · PMID 29186982 · DOI 10.1177/1049909117744554 -
Advance care planning for adults with heart failure.
Nishikawa Y, Hiroyama N, Fukahori H, Ota E, et al · · 2020 · cited 30× · PMID 32104908 · DOI 10.1002/14651858.cd013022.pub2 -
Effect of Advance Care Planning on Surrogate Decision Makers' Preparedness for Decision Making: Results of a Mixed-Methods Randomized Controlled Trial.
Thiede E, Levi BH, Lipnick D, Johnson R, et al · · 2021 · cited 14× · PMID 33373538 · DOI 10.1089/jpm.2020.0238 -
Surrogate Decision Maker Stress in Advance Care Planning Conversations: A Mixed-Methods Analysis From a Randomized Controlled Trial.
Lipnick D, Green M, Thiede E, Smith TJ, et al · · 2020 · cited 14× · PMID 32645452 · DOI 10.1016/j.jpainsymman.2020.07.001 -
Family Caregivers' Characterization of Conversations Following an ACP Event.
Schubart JR, Reading JM, Penrod J, Stewart RR, et al · · 2018 · cited 12× · PMID 30071784 · DOI 10.1177/1049909118760302 -
What Surrogates Understand (and Don't Understand) About Patients' Wishes After Engaging Advance Care Planning: A Qualitative Analysis.
Simmons DB, Levi BH, Green MJ, La IS, et al · · 2022 · cited 7× · PMID 34164999 · DOI 10.1177/10499091211026674 -
Intrinsic Traits Such as Personality and Decision-Making Style are Predictive of Stress in Surrogate Decision-Makers.
Van Scoy LJ, Bliton CF, Smith T, Badzek L, et al · · 2023 · cited 5× · PMID 36266775 · DOI 10.1177/10499091221135594 -
Conceptualization of Surrogate Decision-making Among Spokespersons for Chronically Ill Patients.
Van Scoy LJ, Green MJ, Smith T, VanDyke E, et al · · 2022 · cited 4× · PMID 36480203 · DOI 10.1001/jamanetworkopen.2022.45608
Verify or expand the search:
- PubMed search for NCT02429479
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neoplasms
Currently open trials in the same condition.
- NCT07438782 — First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combinatio · Phase 1 · recruiting
- NCT07382817 — Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms · Phase 1 · recruiting
- NCT07277270 — A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tum · Phase 1 · recruiting
- NCT07257640 — IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia · Phase 1 · recruiting
- NCT07213609 — A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer · Phase 1, PHASE2 · recruiting
Other Milton S. Hershey Medical Center trials
Trials by the same sponsor.
- NCT05180552 — The HEALiX: Comparing the Efficacy of the HEALiX Device With Wrist Restraints in a Critical Care Setting · NA · withdrawn
- NCT07461844 — Transdiagnostic Sleep and Circadian Treatment for Autistic Adults · NA · not yet recruiting
- NCT06253858 — Ultrasound (US) Guided External Ventricular Catheter Placement · NA · not yet recruiting
- NCT07225699 — IN PATIENTS WITH CORNEAL ABRASIONS TREATED WITH COLLAGEN CORNEAL SHIELDS IN THE EMERGENCY DEPARTMENT SETTING · NA · not yet recruiting
- NCT07461168 — Penn State Emergency Medicine CarES: Care-partner Evaluation and Sourcing in the Emergency Department · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02429479 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Milton S. Hershey Medical Center
- Last refreshed: 26 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02429479.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing